Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.81
-0.44 (-3.32%)
At close: Apr 28, 2026, 4:00 PM EDT
13.06
+0.25 (1.95%)
After-hours: Apr 28, 2026, 5:48 PM EDT
Cullinan Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -219.88 | -167.38 | -153.16 | 111.21 | -65.57 | |
| Depreciation & Amortization | 0.31 | 0.31 | 0.31 | 0.09 | 0.05 | |
| Loss (Gain) From Sale of Assets | - | - | - | -276.86 | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.44 | - | - | |
| Loss (Gain) From Sale of Investments | -6.31 | -15.47 | -10.15 | 1.4 | 3.1 | |
| Stock-Based Compensation | 36.04 | 37.82 | 30.44 | 27.96 | 24.38 | |
| Other Operating Activities | - | -0.19 | -1.94 | -2.02 | -1.85 | |
| Change in Accounts Payable | -0.84 | -0.81 | -0.17 | -0.51 | -4.84 | |
| Change in Income Taxes | - | - | -4.28 | 4.28 | - | |
| Change in Other Net Operating Assets | 14.92 | 0.42 | 4.11 | 7.4 | 1.29 | |
| Operating Cash Flow | -175.75 | -145.3 | -134.28 | -126.66 | -43.43 | |
| Capital Expenditures | -0.05 | - | -0.21 | -1.13 | - | |
| Sale of Property, Plant & Equipment | - | - | - | 0.09 | - | |
| Divestitures | - | - | - | 275 | - | |
| Investment in Securities | 180.04 | -136.31 | 36.01 | -24.98 | -333.78 | |
| Investing Cash Flow | 179.99 | -136.31 | 35.81 | 248.98 | -333.78 | |
| Short-Term Debt Issued | - | - | 1.83 | 2.38 | - | |
| Total Debt Issued | - | - | 1.83 | 2.38 | - | |
| Short-Term Debt Repaid | - | - | - | -2.2 | - | |
| Total Debt Repaid | - | - | - | -2.2 | - | |
| Net Debt Issued (Repaid) | - | - | 1.83 | 0.18 | - | |
| Issuance of Common Stock | 1.09 | 270.64 | 38.93 | 6.02 | 270.55 | |
| Other Financing Activities | - | -4.45 | - | -32.13 | -1.77 | |
| Financing Cash Flow | 1.09 | 266.19 | 40.75 | -25.93 | 268.78 | |
| Net Cash Flow | 5.33 | -15.43 | -57.72 | 96.38 | -108.42 | |
| Free Cash Flow | -175.8 | -145.3 | -134.48 | -127.8 | -43.43 | |
| Free Cash Flow Margin | - | - | - | - | -229.28% | |
| Free Cash Flow Per Share | -2.98 | -2.70 | -3.24 | -2.74 | -1.01 | |
| Cash Income Tax Paid | -2.97 | -2.27 | -4.43 | 37.8 | - | |
| Levered Free Cash Flow | -100.28 | -84.86 | -88.76 | -47.6 | -24.64 | |
| Unlevered Free Cash Flow | -100.28 | -84.86 | -88.76 | -47.6 | -24.64 | |
| Change in Working Capital | 14.08 | -0.39 | -0.34 | 11.18 | -3.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.